Trial Profile
A crossover study to evaluate Dipeptidyl peptidase-4 inhibition with alogliptin in type 2 diabetic patients with incipient nephropathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Dec 2015 New trial record